Cargando…

Pyrido[3,4-d]pyrimidin-4(3H)-one metabolism mediated by aldehyde oxidase is blocked by C2-substitution

1. We have previously described C8-substituted pyrido[3,4-d]pyrimidin-4(3H)-one derivatives as cell permeable inhibitors of the KDM4 and KDM5 subfamilies of JmjC histone lysine demethylases. 2. Although exemplar compound 1 exhibited moderate clearance in mouse liver microsomes, it was highly cleared...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hayes, Angela, Mok, N. Yi, Liu, Manjuan, Thai, Ching, Henley, Alan T., Atrash, Butrus, Lanigan, Rachel M., Sejberg, Jimmy, Le Bihan, Yann-Vaï, Bavetsias, Vassilios, Blagg, Julian, Raynaud, Florence I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2016
Materias:	General Xenobiochemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526139/ https://www.ncbi.nlm.nih.gov/pubmed/27618572 http://dx.doi.org/10.1080/00498254.2016.1230245

Ejemplares similares

8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase Inhibitors
por: Bavetsias, Vassilios, et al.
Publicado: (2016)

Metabolism of the dual FLT-3/Aurora kinase inhibitor CCT241736 in preclinical and human in vitro models: Implication for the choice of toxicology species
por: Wood, Francesca L., et al.
Publicado: (2019)

C8-substituted pyrido[3,4-d]pyrimidin-4(3H)-ones: Studies towards the identification of potent, cell penetrant Jumonji C domain containing histone lysine demethylase 4 subfamily (KDM4) inhibitors, compound profiling in cell-based target engagement assays
por: Le Bihan, Yann-Vaï, et al.
Publicado: (2019)

7-(Pyrazol-4-yl)-3H-imidazo[4,5-b]pyridine-based derivatives for kinase inhibition: Co-crystallisation studies with Aurora-A reveal distinct differences in the orientation of the pyrazole N1-substituent
por: Bavetsias, Vassilios, et al.
Publicado: (2015)

Pyrido-Fused Deazapurine Bases: Synthesis and Glycosylation of 4-Substituted 9H-Pyrido[2′,3′:4,5]- and Pyrido[4′,3′:4,5]pyrrolo[2,3-d]pyrimidines
por: Veselovská, Lucia, et al.
Publicado: (2020)

Optimization of Imidazo[4,5-b]pyridine-Based Kinase Inhibitors: Identification of a Dual FLT3/Aurora Kinase Inhibitor as an Orally Bioavailable Preclinical Development Candidate for the Treatment of Acute Myeloid Leukemia
por: Bavetsias, Vassilios, et al.
Publicado: (2012)

Aurora Isoform Selectivity: Design and Synthesis of Imidazo[4,5-b]pyridine Derivatives as Highly Selective Inhibitors of Aurora-A Kinase in Cells
por: Bavetsias, Vassilios, et al.
Publicado: (2013)

Studies of Interaction Mechanism between Pyrido [3,4-d] Pyrimidine Inhibitors and Mps1
por: Xing, Cheng, et al.
Publicado: (2021)

Exploration of Pyrido[3,4-d]pyrimidines as Antagonists of the Human Chemokine Receptor CXCR2
por: Van Hoof, Max, et al.
Publicado: (2023)

Electro-Oxidative C3-Selenylation of Pyrido[1,2-a]pyrimidin-4-ones
por: Shi, Jianwei, et al.
Publicado: (2023)

Design and Synthesis of a Series of Pyrido[2,3-d]pyrimidine Derivatives as CCR4 Antagonists
por: Gong, Hongwei, et al.
Publicado: (2012)

3-(2-Chloroethyl)-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
por: Jasinski, Jerry P., et al.
Publicado: (2009)

Introduction of a Methyl Group Curbs Metabolism of Pyrido[3,4-d]pyrimidine Monopolar Spindle 1 (MPS1) Inhibitors and Enables the Discovery of the Phase 1 Clinical Candidate N(2)-(2-Ethoxy-4-(4-methyl-4H-1,2,4-triazol-3-yl)phenyl)-6-methyl-N(8)-neopentylpyrido[3,4-d]pyrimidine-2,8-diamine (BOS172722)
por: Woodward, Hannah L., et al.
Publicado: (2018)

Pyridine-Based Heterocycles. Synthesis of New Pyrido [4',3':4,5]thieno[2,3-d]pyrimidines and Related Heterocycles
por: El-Kashef, Hussein, et al.
Publicado: (2010)

Review on the Synthesis and Therapeutic Potential of Pyrido[2,3-d], [3,2-d], [3,4-d] and [4,3-d]pyrimidine Derivatives
por: Campos, Joana F., et al.
Publicado: (2022)

Selective FLT3 inhibition of FLT3-ITD(+) acute myeloid leukaemia resulting in secondary D835Y mutation: a model for emerging clinical resistance patterns
por: Moore, Andrew S., et al.
Publicado: (2012)

Hexafluoroisopropyl alcohol mediated synthesis of 2,3-dihydro-4H-pyrido[1,2-a]pyrimidin-4-ones
por: Alam, Mohammad A., et al.
Publicado: (2016)

Metal free C-3 chalcogenation (sulfenylation and selenylation) of 4H-pyrido[1,2-a]pyrimidin-4-ones
por: Ghosh, Prasanjit, et al.
Publicado: (2021)

Structure-Based Design of Orally Bioavailable 1H-Pyrrolo[3,2-c]pyridine Inhibitors of Mitotic Kinase Monopolar Spindle 1 (MPS1)
por: Naud, Sébastien, et al.
Publicado: (2013)

Spiro[cyclopentane-1,2′(1′H)-pyrido[2,3-d]pyrimidin]-4′(3′H)-one
por: Shi, Daxin, et al.
Publicado: (2010)

Medicinal chemistry perspective of pyrido[2,3-d]pyrimidines as anticancer agents
por: Kumar, Adarsh, et al.
Publicado: (2023)

Aquabis(2,3-dimethyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-olato)nickel(II)
por: Zhang, Huaihong, et al.
Publicado: (2009)

Synthesis of N-Bridged Pyrido[4,3-d]pyrimidines and Self-Assembly into Twin Rosette Cages and Nanotubes in Organic Media
por: Igci, Cansu, et al.
Publicado: (2018)

Design, Synthesis and Bioactivity Evaluation of 4,6-Disubstituted Pyrido[3,2-d]pyrimidine Derivatives as Mnk and HDAC Inhibitors
por: Xing, Kun, et al.
Publicado: (2020)

Synthesis and In Silico Docking of New Pyrazolo[4,3-e]pyrido[1,2-a]pyrimidine-based Cytotoxic Agents
por: Horchani, Mabrouk, et al.
Publicado: (2021)

6′-Bromo-1′H-spiro[cyclohexane-1,2′-pyrido[2,3-d]pyrimidin]-4′(3′H)-one
por: Yang, Liupan, et al.
Publicado: (2011)

Pyrido[2,3-d]pyrimidin-7(8H)-ones: Synthesis and Biomedical Applications
por: Jubete, Guillem, et al.
Publicado: (2019)

Synthesis and cytotoxic evaluation of some novel 3-[2-(2-phenyl-thiazol-4-yl)-ethyl]-3H-pyrido[2,3-d]pyrimidin-4-one derivatives
por: Rahmani Khajouei, Marzieh, et al.
Publicado: (2021)

Synthesis, Antitumor Activity, and Docking Analysis of New Pyrido[3′,2′:4,5]furo(thieno)[3,2-d]pyrimidin-8-amines
por: Sirakanyan, Samvel N., et al.
Publicado: (2019)

From Quinoxaline, Pyrido[2,3-b]pyrazine and Pyrido[3,4-b]pyrazine to Pyrazino-Fused Carbazoles and Carbolines
por: Lassagne, Frédéric, et al.
Publicado: (2018)

6-Benzyl 4-ethyl 2-chloro-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine-4,6-dicarboxylate
por: Guo, Huan-Mei
Publicado: (2011)

Triethylammonium Hydrogen Sulfate [Et(3)NH][HSO(4)]-Catalyzed Rapid and Efficient Multicomponent Synthesis of Pyrido[2,3-d]pyrimidine and Pyrazolo[3,4-b]pyridine Hybrids
por: Jadhav, Chetan, et al.
Publicado: (2021)

Crystal Structure of Pim1 Kinase in Complex with a Pyrido[4,3-D]Pyrimidine Derivative Suggests a Unique Binding Mode
por: Lee, Sang Jae, et al.
Publicado: (2013)

Microwave-Assisted Synthesis of Potential Bioactive Benzo-, Pyrido- or Pyrazino-thieno[3,2-d]pyrimidin-4-amine Analogs of MPC-6827
por: Loidreau, Yvonnick, et al.
Publicado: (2020)

Design, Synthesis and SAR in 2,4,7-Trisubstituted Pyrido[3,2-d]Pyrimidine Series as Novel PI3K/mTOR Inhibitors
por: Buron, Frédéric, et al.
Publicado: (2021)

Evaluation of Neurotropic Activity and Molecular Docking Study of New Derivatives of pyrano[4″,3″:4′,5′]pyrido[3′,2′:4,5]thieno[3,2-d]pyrimidines on the Basis of pyrano[3,4-c]pyridines
por: Dashyan, Shushanik Sh., et al.
Publicado: (2022)

6-(2,6-Dimethylphenyl)pyrido[2,3-d]pyrimidin-7-amine
por: Nukui, Seiji, et al.
Publicado: (2009)

SnAr Reactions of 2,4-Diazidopyrido[3,2-d]pyrimidine and Azide-Tetrazole Equilibrium Studies of the Obtained 5-Substituted Tetrazolo[1,5-a]pyrido[2,3-e]pyrimidines
por: Leškovskis, Kristaps, et al.
Publicado: (2022)

Catalytic Photoredox C–H Arylation of 4-Oxo-4H-pyrido[1,2-a]pyrimidine-3-diazonium Tetrafluoroborates and Related Heteroaryl Diazonium Salts
por: Antolinc, Kris, et al.
Publicado: (2023)

7-Benzyl-3-(4-fluorophenyl)-2-propylamino-5,6,7,8-tetrahydropyrido[4′,3′:4,5]thieno[2,3-d]pyrimidin-4(3H)-one
por: Hu, Hai-Jun, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_2i6d5uk7rpoajlmsi7v9u0m31i